We specialise in applied methodology research which allows exploration and delivery of complex trials applicable in the real-world to benefit people affected by cancer and improve the quality of future oncology research, while also assessing innovative methodology approaches.  Areas of interest include:

• biomarker-rich trials and trial platforms
• biological endpoints
• technical radiotherapy studies
• imaging biomarkers
• patient reported outcomes
• use of routine data
• equality, diversity and inclusion
• efficient early phase adaptive designs
• integration of omics and clinical data